Test Code BRSTSO Invitae Breast Cancer STAT Panel (50001)
Additional Codes
Invitae Test Code: 50001
Useful For
All genes on this panel have published medical management guidelines and are associated with defined hereditary cancer syndromes.
This test is appropriate for breast cancer patients with upcoming cancer-related breast surgeries and/or treatment where genetic testing may inform decisions such as lumpectomy versus mastectomy, single versus double mastectomy, or use of other treatments (such as use of PARP inhibitors or other chemotherapy regimens). Identification of a disease-causing variant may also guide testing and management of at-risk relatives. This test is specifically designed for heritable germline mutations and is not appropriate for the detection of somatic mutations in tumor tissue.
Specimen Requirements
| Submit one of the following specimens: | ||||||
|---|---|---|---|---|---|---|
| Fasting Required | Specimen Type | Preferred Container/Tube | Acceptable Container/Tube | Specimen Volume | Specimen Minimum Volume (allows for 1 repeat) |
Pediatric Minimum Volume (no repeat) |
| No | Whole Blood | EDTA Lavender Top Tube (LTT) | 3 mL | 1.5 mL | ||
| No | Saliva | Oragene self collection kit | 2 mL for OG500/OGD500 and 1 mL for OGD510 | |||
Collection/Processing Instructions
Blood should be shipped overnight at room temperature.
Store saliva at room temperature, avoiding lengthy refrigeration. Although there are no special time requirements, we recommend that the specimen be mailed to Invitae soon after collection.
Saliva collected and stored in an OrageneTM self collection kit (OG500/OGD500/OGD510)
- Please note that this kit requires 2 mL of saliva for OG500/OGD500 and 1 mL of saliva for OGD510, and involves active (not assisted) saliva donation.
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Saliva | Ambient | No special requirements |
| Whole Blood | Ambient | 48 hours |
| Refrigerated | 14 days |
Rejection Criteria
| Hemolyzed, clotted, or frozen blood |
|---|
| Blood or saliva from patients who have had an allogeneic (non-self donor) bone marrow transplant |
| Blood or saliva from patients who have had an allogeneic (non-self donor) stem cell transplant |
| Blood or saliva from patients who had a blood transfusion less than two weeks prior to specimen collection |
| Saliva in any other container other than Oragene kits |
| Assisted saliva and gDNA are not accepted |
Test Information
The Invitae Breast Cancer STAT Panel includes up to 9 well-established genes that are associated with a significantly increased risk of developing breast cancer. Accelerated turnaround time (TAT) is needed because physicians and patients often want to make surgical and management decisions as quickly as possible. Individuals who are identified with an inherited pathogenic variant have a higher risk of developing another breast cancer and may choose more aggressive surgery and/or different treatment options based on genetic testing results.
All genes on this panel have published medical management guidelines and are associated with defined hereditary cancer syndromes.
This test is appropriate for breast cancer patients with upcoming cancer-related breast surgeries and/or treatment where genetic testing may inform decisions such as lumpectomy versus mastectomy, single versus double mastectomy, or use of other treatments (such as use of PARP inhibitors or other chemotherapy regimens). Identification of a disease-causing variant may also guide testing and management of at-risk relatives. This test is specifically designed for heritable germline mutations and is not appropriate for the detection of somatic mutations in tumor tissue.
Interpretations
An interpretive report will be provided
Reference Range Information
An interpretive report will be provided
Performing Laboratory Name
Invitae
Referral Laboratory Information
| Address | Telephone | Website Link |
|---|---|---|
| 1400 16th Street
San Francisco, CA 94103 |
800-436-3037 |
Performing Information
| Performing Location | Day(s) Test Performed | Analytical Time | Methodology/Instrumentation |
|---|---|---|---|
| Invitae | Monday through Saturday | 5 to 12 days | Next Generation Sequencing Deletion/Duplication Analysis |
CPT Codes
| CPT | Modifier (if needed) |
Quantity | Description | Comments |
|---|---|---|---|---|
| 81162 | 1 | BRCA1, BRCA2 gene analysis; full sequenceanalysis and full duplication/deletion analysis |
Outreach CPT Codes
| CPT | Modifier (if needed) |
Quantity | Description | Comments |
|---|---|---|---|---|
| 81162 | 1 | BRCA1, BRCA2 gene analysis; full sequenceanalysis and full duplication/deletion analysis |
Ordering Applications
| Ordering Application | Description |
|---|---|
| COM | Invitae Breast Cancer STAT Panel (#50001) |
| Cerner | Invitae Breast Cancer STAT Panel (#50001) |